Significantly variable serum polyunsaturated fatty acid metabolites. by Patrick C. Barko (10668358)

“…Linear mixed-effects models were used to identify serum metabolites that varied significantly among the storage conditions. …”

Significantly variable serum amino acid and gamma-glutamyl amino acid metabolites. by Patrick C. Barko (10668358)

“…Linear mixed-effects models were used to identify serum metabolites that varied significantly among the storage conditions. …”

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. by Matthew Drill (22258391)

Subjects:

Scatterplot of observed barrier scores against knowledge scores (top) and confidence scores (bottom) with linear line of best fit. by Lisa Thiele (6468056)

Subjects:

Multiple linear regression analysis of the RAAS and glucose metabolism indicators before and after treatment in DKD and non-DKD patients. by Ningning Wang (560944)

Subjects:

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

Linear regression analysis of changes of E’ and LVGLS with hemodynamic data (N = 29). by Ho-Min Yoon (18310064)

Subjects:

Linear regression analysis of baseline E’ and LVGLS with hemodynamic data (N = 29). by Ho-Min Yoon (18310064)

Subjects:

N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease. by Noelia Carballeda-Sangiao (2889611)

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

The summarized graph for the values of the coefficients of significant linear trends. by Ekaterina Ivanova (230383)

Hierarchical linear regression models for wave 3 alcohol use frequency. by Karen G. Chartier (11714643)

Subjects:

Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

The linearly decreasing convergence factor a. by Junhao Wei (6816803)